Social Medical Progression of Coronary Heart Disease With Associated Psychosocial Comorbidity -Interval Rehabilitation. (SINKO)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01589536|
Recruitment Status : Unknown
Verified April 2012 by Clinic Roderbirken.
Recruitment status was: Recruiting
First Posted : May 2, 2012
Last Update Posted : May 2, 2012
|Condition or disease||Intervention/treatment||Phase|
|Cardiovascular Events||Other: interval-rehabilitation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||480 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Improvement of the Social Medical Progression of Coronary Heart Disease With Associated Psychosocial Comorbidity by the Use of Interval Rehabilitation.|
|Study Start Date :||October 2011|
|Estimated Primary Completion Date :||December 2015|
|Estimated Study Completion Date :||December 2016|
A Stationary psychocardiological interval-rehabilitation.
The Patients in the intervention group receive a Stationary psychocardiological interval-rehabilitation.The Interval rehabilitation is divided into individual psychological therapy with focus of Behavior therapy and relaxation therapy.
No Intervention: controlgroup
The Patients in the control group receive a personal recommendation concerning psychotherapy outpatient counseling and therapy services at home and take therapeutic help.
- Improvement of the social medical progression of coronary heart disease with associated psychosocial comorbidity by the use of interval rehabilitaion [ Time Frame: 24 months after including study ]Reducing the rate of disability pension of 18%of 9% by interval-rehabilitation with aftercare.
- Improvement of the social medical progression of coronary heart disease with associated psychosocial comorbidity by the use of interval rehabilitaion [ Time Frame: 24 months after including study ]Reduction of cardiovascular events, including deaths Improving the risk profile Improvement of health-related quality of life Improvement of mental comorbidity
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01589536
|Leichlingen, NRW, Germany, 42799|
|Contact: Sarah Neuhaeuser :+ 49 (2175) 82 - 3352 firstname.lastname@example.org|
|Contact: Wolfgang Mayer-Berger, Dr. med. +49 (2175) 82-4010 email@example.com|
|Principal Investigator: Wolfgang Mayer-Berger, Dr.med.|
|Principal Investigator:||Wolfgang Mayer-Berger, MD||Clinic Roderbirken|